Immunotherapy Added to Standard Treatment Shows Early Promise Against Aggressive Brain Tumors
A retrospective study of 25 patients suggests that adding the anti-PD-1 antibody pucotenlimab to concurrent radiochemotherapy produced tumor responses and ...
